David Fisher has been appointed Commercial Director of the ABPI, a new post within the organisation.
Mr Fisher has 25 years’ experience within the pharmaceutical industry in both the UK and US. He joins the ABPI from Maritz, where he was European Sales Director, and Pharmaceutical Sector Lead. Before this he held several Senior Marketing and Sales Management roles at sanofi-aventis and Pfizer.
The new role of Commercial Director will involve developing and implementing UK commercial strategy policy for the industry and assisting the Director General in representing the ABPI views to government, industry bodies and the media. High on his agenda will be expanding patients’ access to innovative medicines and deepening working relationships across the NHS, to assist PCOs and medical professionals to improve the productivity with which they manage chronic disease. The role of the PPRS in maintaining a strong environment for the global industry in the UK will also form part of his responsibilities, which will span England, Scotland, Wales and N. Ireland.
“The ability of the UK pharmaceutical industry to remain innovative and globally competitive relies on a sound commercial environment,” said David Fisher. “I am looking forward to taking an industry wide role in helping to achieve this.”
ABPI Director General Dr Richard Barker said: “We are entering an exciting time of change for our primary customer, the NHS, and the industry’s relationships with the NHS are of more importance than ever. I have every confidence that, with his wealth of experience, David will help lead the ABPI future commercial and trade policy to a position of further strength."
For further information, please contact: ABPI Press office: 020 7747 1410